Overview adapted from the main GPCRdb reference

References

1. GPCRDB: an information system for G protein-coupled receptors.
Isberg, V., Vroling, B., van der Kant, R., Li, K., Vriend, G. and Gloriam, D.
Nucleic Acids Research, 2014

2. GPCRdb: an information system for G protein-coupled receptors.
Isberg, V., Mordalski, S., Munk, C., Rataj, K., Harpsoe, K., Hauser, A.S., Vroling, B., Bojarski, A.J., Vriend, G. and Gloriam, D.E.
Nucleic Acids Research, 2016

3. GPCRdb in 2021: integrating GPCR sequence, structure and function.
Kooistra, A.J., Mordalski, S., Pándy-Szekeres, G., Esguerra, M., Mamyrbekov, A., Munk, C., Keserű, G.M. and Gloriam, D.E.
Nucleic Acids Research, 2021

4. Generic GPCR residue numbers - aligning topology maps while minding the gaps.
Isberg, V., de Graaf, C., Bortolato, A., Cherezov, V., Katritch, V., Marshall, F.H., Mordalski, S., Pin, J.P., Stevens, R.C., Vriend, G. and Gloriam, D.E.
Trends in pharmacological sciences, 2015

5. Pharmacogenomics of GPCR Drug Targets.
Hauser, A.S., Chavali, S., Masuho, I., Jahn, L.J., Martemyanov, K.A., Gloriam, D.E. and Babu, M.M.
Cell, 2018

6. Combinatorial expression of GPCR isoforms affects signalling and drug responses.
Marti-Solano, M., Crilly, S.E., Malinverni, D., Munk, C., Harris, M., Pearce, A., Quon, T., Mackenzie, A.E., Wang, X., Peng, J. et al.
Nature, 2020

7. GPCRdb: the G protein-coupled receptor database - an introduction.
Munk, C., Isberg, V., Mordalski, S., Harpsoe, K., Rataj, K., Hauser, A.S., Kolb, P., Bojarski, A.J., Vriend, G. and Gloriam, D.E.
British Journal of Pharmacololgy, 2016

8. Main reference GPCRdb in 2023: State-specific structure models using AlphaFold2 and expansion of ligand resources.
Pándy-Szekeres, G., Caroli, J., Mamyrbekov, A., Kermani, A.A., Keserű, G.M., Kooistra, A.J. and Gloriam, D.E.
Nucleic Acids Research, 2023

9. An online GPCR structure analysis platform.
Kooistra, A.J., Munk, C., Hauser, A.S. and Gloriam, D.E.
Nature Structural & Molecular Biology, 2021

10. An online resource for GPCR structure determination and analysis.
Munk, C., Mutt, E., Isberg, V., Nikolajsen, L.F., Bibbe, J.M., Flock, T., Hanson, M.A., Stevens, R.C., Deupi, X. and Gloriam, D.E.
Nature Methods, 2019

11. GPCRdb in 2018: adding GPCR structure models and ligands.
Pándy-Szekeres, G., Munk, C., Tsonkov, T.M., Mordalski, S., Harpsoe, K., Hauser, A.S., Bojarski, A.J. and Gloriam, D.E.
Nucleic Acids Research, 2018

12. Trends in GPCR drug discovery: new agents, targets and indications.
Hauser, A.S., Attwood, M.M., Rask-Andersen, M., Schioth, H.B. and Gloriam, D.E.
Nature Reviews Drug Discovery, 2017

13. Integrating structural and mutagenesis data to elucidate GPCR ligand binding.
Munk, C., Harpsoe, K., Hauser, A.S., Isberg, V. and Gloriam, D.E.
Current Opinion in Pharmacology, 2016